Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Kay

Showing results (141-150 of 197) with videos related to

Pageof 20
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2014
Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variantSandra P Melo, Leszek Lisowski, Elizaveta Bashkirova, et al.
Nature Biotechnology|April 8, 2022
Fludarabine increases nuclease-free AAV- and CRISPR/Cas9-mediated homologous recombination in miceShinnosuke Tsuji, Calvin J Stephens, Giulia Bortolussi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2007
Distinct pathways of genomic progression to benign and malignant tumors of the liverAaron D Tward, Kirk D Jones, Stephen Yant, et al.
Gene Therapy|March 30, 2026
First-in-human nuclease-free homologous recombination-dependent gene editing in pediatric patients with methylmalonic acidemia: results of a phase 1/2 studyJirair K Bedoyan, Thomas Morgan, Angela Sun, et al.
Nature|January 7, 2014
Selection and evaluation of clinically relevant AAV variants in a xenograft liver modelLeszek Lisowski, Allison P Dane, Kirk Chu, et al.
JCI Insight|June 19, 2019
Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseasesAlessia De Caneva, Fabiola Porro, Giulia Bortolussi, et al.
Human Gene Therapy|April 14, 2016
A Tribute to George StamatoyannopoulosArun Srivastava, Mark A Kay, Takis Athanasopoulos, et al.
Frontiers in Genome Editing|April 1, 2022
Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal MiceMichela Lisjak, Alessia De Caneva, Thibaut Marais, et al.
Human Gene Therapy|September 26, 2007
Rapid and stable knockdown of an endogenous gene in retinal pigment epitheliumDaniel M Paskowitz, Kenneth P Greenberg, Douglas Yasumura, et al.
Nucleic Acids Research|December 4, 2016
Regulated complex assembly safeguards the fidelity of Sleeping Beauty transpositionYongming Wang, Diana Pryputniewicz-Dobrinska, Enikö Éva Nagy, et al.
Pageof 20

Showing results (141-150 of 197) with videos related to

Sort By:
Pageof 20
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2014
Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variantSandra P Melo, Leszek Lisowski, Elizaveta Bashkirova, et al.
Nature Biotechnology|April 8, 2022
Fludarabine increases nuclease-free AAV- and CRISPR/Cas9-mediated homologous recombination in miceShinnosuke Tsuji, Calvin J Stephens, Giulia Bortolussi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2007
Distinct pathways of genomic progression to benign and malignant tumors of the liverAaron D Tward, Kirk D Jones, Stephen Yant, et al.
Gene Therapy|March 30, 2026
First-in-human nuclease-free homologous recombination-dependent gene editing in pediatric patients with methylmalonic acidemia: results of a phase 1/2 studyJirair K Bedoyan, Thomas Morgan, Angela Sun, et al.
Nature|January 7, 2014
Selection and evaluation of clinically relevant AAV variants in a xenograft liver modelLeszek Lisowski, Allison P Dane, Kirk Chu, et al.
JCI Insight|June 19, 2019
Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseasesAlessia De Caneva, Fabiola Porro, Giulia Bortolussi, et al.
Human Gene Therapy|April 14, 2016
A Tribute to George StamatoyannopoulosArun Srivastava, Mark A Kay, Takis Athanasopoulos, et al.
Frontiers in Genome Editing|April 1, 2022
Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal MiceMichela Lisjak, Alessia De Caneva, Thibaut Marais, et al.
Human Gene Therapy|September 26, 2007
Rapid and stable knockdown of an endogenous gene in retinal pigment epitheliumDaniel M Paskowitz, Kenneth P Greenberg, Douglas Yasumura, et al.
Nucleic Acids Research|December 4, 2016
Regulated complex assembly safeguards the fidelity of Sleeping Beauty transpositionYongming Wang, Diana Pryputniewicz-Dobrinska, Enikö Éva Nagy, et al.
Pageof 20